Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Matrix M”

Showing 20 of 0 results

Not applicableLooking for participantsNCT07416461
What this trial is testing

Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease

Who this might be right for
Invasive Non-Typhoidal Salmonella DiseaseMalariaMalaria Vaccine
International Vaccine Institute 10,000
Testing effectiveness (Phase 2)Study completedNCT04201431
What this trial is testing

Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1

Who this might be right for
Malaria, Vivax
University of Oxford 24
Early research (Phase 1)Study completedNCT05155579
What this trial is testing

Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines

Who this might be right for
Malaria
University of Oxford 594
Large-scale testing (Phase 3)Study completedNCT04611802
What this trial is testing

Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 33,000
Testing effectiveness (Phase 2)Study completedNCT03896724
What this trial is testing

Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso

Who this might be right for
Malaria,Falciparum
University of Oxford 450
Early research (Phase 1)Study completedNCT02572388
What this trial is testing

Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1

Who this might be right for
Malaria
University of Oxford 31
Large-scale testing (Phase 3)WithdrawnNCT06482359
What this trial is testing

Lot Consistency Study of COVID-19 and Influenza Combination Vaccine

Who this might be right for
COVID-19Influenza
Novavax
Testing effectiveness (Phase 2)Active Not RecruitingNCT07147400
What this trial is testing

Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults

Who this might be right for
Prevention of Malaria Transmission and Clinical Malaria
Serum Institute of India Pvt. Ltd. 1,200
Early research (Phase 1)Ended earlyNCT04271306
What this trial is testing

Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania.

Who this might be right for
Malaria,Falciparum
University of Oxford 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT06549257
What this trial is testing

Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 56
Early research (Phase 1)Active Not RecruitingNCT06320535
What this trial is testing

Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™

Who this might be right for
Malaria,Falciparum
University of Oxford 36
Very early researchEnded earlyNCT05270265
What this trial is testing

Safety and Immunogenicity of Pvs25-IMX313/Matrix-M1 Vaccine

Who this might be right for
Malaria, Vivax
University of Oxford 25
Post-approval studies (Phase 4)Looking for participantsNCT07038837
What this trial is testing

Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad

Who this might be right for
Malaria InfectionMalaria Vaccines
Epicentre 70,000
Post-approval studies (Phase 4)Not Yet RecruitingNCT07194668
What this trial is testing

R21/MM Dosing, Presentations, and Preservatives

Who this might be right for
Plasmodium Falciparum MalariaMalariaVaccine Reaction
University of Oxford 375
Testing effectiveness (Phase 2)Ended earlyNCT03658629
What this trial is testing

Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults

Who this might be right for
Influenza, Human
Novavax 1,375
Not applicableStudy completedNCT07310732
What this trial is testing

Clinical and Radiographic Assessment of Efficacy of Modified Minimally Invasive SurgicalTechnique (M-MIST) Alone and Combined With Enamel Matrix Proteins and Ox-derived Bone Graft in the Treatment of Single Bone Defects Between Teeth.

Who this might be right for
Periodontal DiseasesPeriodontal Bone Loss
Rungta College of Dental Sciences and Research 45
Early research (Phase 1)Ended earlyNCT04130282
What this trial is testing

VAC077: Safety and Immunogenicity of the Pfs25-IMX313/Matrix-M Vaccine

Who this might be right for
Malaria,Falciparum
University of Oxford 1
Testing effectiveness (Phase 2)Study completedNCT03293498
What this trial is testing

Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu)

Who this might be right for
Influenza
Novavax 330
Early research (Phase 1)Study completedNCT02370589
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects

Who this might be right for
Ebola
Novavax 230
Testing effectiveness (Phase 2)Study completedNCT06695130
What this trial is testing

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older

Who this might be right for
COVID-19 ImmunizationInfluenza Immunization
Sanofi 980
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation